These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Titin-truncating variants affect heart function in disease cohorts and the general population. Schafer S; de Marvao A; Adami E; Fiedler LR; Ng B; Khin E; Rackham OJ; van Heesch S; Pua CJ; Kui M; Walsh R; Tayal U; Prasad SK; Dawes TJ; Ko NS; Sim D; Chan LL; Chin CW; Mazzarotto F; Barton PJ; Kreuchwig F; de Kleijn DP; Totman T; Biffi C; Tee N; Rueckert D; Schneider V; Faber A; Regitz-Zagrosek V; Seidman JG; Seidman CE; Linke WA; Kovalik JP; O'Regan D; Ware JS; Hubner N; Cook SA Nat Genet; 2017 Jan; 49(1):46-53. PubMed ID: 27869827 [TBL] [Abstract][Full Text] [Related]
29. Association of Pathogenic DNA Variants Predisposing to Cardiomyopathy With Cardiovascular Disease Outcomes and All-Cause Mortality. Patel AP; Dron JS; Wang M; Pirruccello JP; Ng K; Natarajan P; Lebo M; Ellinor PT; Aragam KG; Khera AV JAMA Cardiol; 2022 Jul; 7(7):723-732. PubMed ID: 35544052 [TBL] [Abstract][Full Text] [Related]
30. European ancestry as a risk factor for atrial fibrillation in African Americans. Marcus GM; Alonso A; Peralta CA; Lettre G; Vittinghoff E; Lubitz SA; Fox ER; Levitzky YS; Mehra R; Kerr KF; Deo R; Sotoodehnia N; Akylbekova M; Ellinor PT; Paltoo DN; Soliman EZ; Benjamin EJ; Heckbert SR; Circulation; 2010 Nov; 122(20):2009-15. PubMed ID: 21098467 [TBL] [Abstract][Full Text] [Related]
31. Poor prognosis of rare sarcomeric gene variants in patients with dilated cardiomyopathy. Merlo M; Sinagra G; Carniel E; Slavov D; Zhu X; Barbati G; Spezzacatene A; Ramani F; Salcedo E; Di Lenarda A; Mestroni L; Taylor MR; Clin Transl Sci; 2013 Dec; 6(6):424-8. PubMed ID: 24119082 [TBL] [Abstract][Full Text] [Related]
32. Association of Race With Disease Expression and Clinical Outcomes Among Patients With Hypertrophic Cardiomyopathy. Eberly LA; Day SM; Ashley EA; Jacoby DL; Jefferies JL; Colan SD; Rossano JW; Semsarian C; Pereira AC; Olivotto I; Ingles J; Seidman CE; Channaoui N; Cirino AL; Han L; Ho CY; Lakdawala NK JAMA Cardiol; 2020 Jan; 5(1):83-91. PubMed ID: 31799990 [TBL] [Abstract][Full Text] [Related]
33. Toward Genetics-Driven Early Intervention in Dilated Cardiomyopathy: Design and Implementation of the DCM Precision Medicine Study. Kinnamon DD; Morales A; Bowen DJ; Burke W; Hershberger RE; Circ Cardiovasc Genet; 2017 Dec; 10(6):. PubMed ID: 29237686 [TBL] [Abstract][Full Text] [Related]
34. Truncating titin mutations are associated with a mild and treatable form of dilated cardiomyopathy. Jansweijer JA; Nieuwhof K; Russo F; Hoorntje ET; Jongbloed JD; Lekanne Deprez RH; Postma AV; Bronk M; van Rijsingen IA; de Haij S; Biagini E; van Haelst PL; van Wijngaarden J; van den Berg MP; Wilde AA; Mannens MM; de Boer RA; van Spaendonck-Zwarts KY; van Tintelen JP; Pinto YM Eur J Heart Fail; 2017 Apr; 19(4):512-521. PubMed ID: 27813223 [TBL] [Abstract][Full Text] [Related]
35. Enrichment of titin-truncating variants in exon 327 in dilated cardiomyopathy and its relevance to reduced nonsense-mediated mRNA decay efficiency. Kim YG; Ha C; Shin S; Park JH; Jang JH; Kim JW Front Genet; 2022; 13():1087359. PubMed ID: 36685919 [TBL] [Abstract][Full Text] [Related]
36. Role of titin in cardiomyopathy: from DNA variants to patient stratification. Ware JS; Cook SA Nat Rev Cardiol; 2018 Apr; 15(4):241-252. PubMed ID: 29238064 [TBL] [Abstract][Full Text] [Related]
37. Amino Acid-Level Signal-to-Noise Analysis Aids in Pathogenicity Prediction of Incidentally Identified Connell PS; Berkman AM; Souder BM; Pirozzi EJ; Lovin JJ; Rosenfeld JA; Liu P; Tunuguntla H; Allen HD; Denfield SW; Kim JJ; Landstrom AP Circ Genom Precis Med; 2021 Feb; 14(1):e003131. PubMed ID: 33226272 [TBL] [Abstract][Full Text] [Related]